Clorox (CLX) insider buying and selling
Every Table I transaction reported by directors and officers of S&P 500 companies on SEC Form 4 filings (2 business days to file): each row labeled with its official transaction code, nothing filtered out beforehand.
Open-market purchases (code P) are the rare signal, in green; sales (code S) are common and often pre-scheduled (10b5-1). Table II (derivatives) is not included: its prices are exercise prices, not market values. Guide: insider buying.
| Date | Ticker | Insider | Role | Shares | Price | Amount | % of stake | Type / filing |
|---|
Download these transactions as CSV No account, no sign-up. The data is public: it comes from SEC Form 4 filings.
The Clorox Company (CLX) insider buying and selling: 2 purchases, 1 sale
66 Form 4 Table I transactions filed with the SEC by The Clorox Company insiders between 2025-09-08 and 2026-10-07 (15-month history): 2 open-market purchases and 1 sale, plus 63 transactions under other Form 4 codes, broken down one by one below. The largest open-market trade is a sale of $1.9M by Reynolds Eric H on 2025-09-04.
Clorox insider buying and selling over the last 12 months
Between Oct 21, 2025 and Oct 20, 2026, Clorox insiders filed 2 purchases worth $846k on the open market, and no sales.
The biggest buyer was Breber Pierre R (Director): $846k in 2 purchases, the only buyer.
The largest trade of the period was a purchase of $429k on May 5, 2026, by Breber Pierre R (Director). Form 4 on sec.gov (0001225208-26-004962).
The last three months show 0 purchases, against 1 in the three before. The latest purchase is from May 5, 2026.
Against its sector (Consumer Defensive, 33 companies with an insider page on this site), over the same dates the median is 5 sales and 1 purchase on the open market. Clorox has no sales, like 0 of the other 32, ranks 3 of 33 by net dollars bought, and 17 of the 33 have at least one purchase, Clorox included.
The 20 most important trades
The 2 open-market purchases first, then the rest, each type from largest to smallest. The full history is in the tool above, already searched.
See all 66 CLX trades in the full history →
| Trade date | Filed | Insider | Role | Amount | Code | Filing |
|---|---|---|---|---|---|---|
| 2026-05-05 | 2026-05-05 | Breber Pierre R | Director | $429k | P — Open-market purchase Indirect holding, through: By Trust Form 4 footnoteF1 This transaction was executed in multiple trades at prices ranging from $85.1900 to $86.0100. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | SEC |
| 2025-11-21 | 2025-11-24 | Breber Pierre R | Director | $417k | P — Open-market purchase Indirect holding, through: By Trust Form 4 footnoteF1 This transaction was executed in multiple trades at prices ranging from $104.00 to $104.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | SEC |
| 2025-09-04 | 2025-09-08 | Reynolds Eric H | EVP - Chief Operating Officer | $1.9M | S — Open-market saleForm 4 footnoteF1 This transaction was executed in multiple trades at prices ranging from $123.731 to $123.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | SEC |
| 2025-10-03 | 2025-10-07 | Rendle Linda J | Chief Executive Officer | $5.3M | A — Grant or awardForm 4 footnoteF1 Settlement of 2022 Performance Unit Grant that vested 10/3/25, which the reporting person has elected to defer pursuant to the 2005 Stock Incentive Plan. | SEC |
| 2025-09-16 | 2025-09-18 | Rendle Linda J | Chief Executive Officer | $4.3M | A — Grant or awardForm 4 footnoteF1 The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2026, 2027, 2028, and 2029. | SEC |
| 2026-09-23 | 2026-09-25 | Rendle Linda J | Chief Executive Officer | $4.3M | A — Grant or awardForm 4 footnoteF1 The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2027, 2028, 2029, and 2030. | SEC |
| 2026-06-17 | 2026-06-22 | Hyder Chris T | EVP-Chief Operating Officer | $4.0M | A — Grant or awardForm 4 footnoteF1 The Restricted Stock Units will vest in full on the third anniversary of the grant date, June 17, 2029. | SEC |
| 2026-06-17 | 2026-06-22 | Bellet Luc | EVP - Chief Financial Officer | $4.0M | A — Grant or awardForm 4 footnoteF1 The Restricted Stock Units will vest in full on the third anniversary of the grant date, June 17, 2029. | SEC |
| 2026-06-17 | 2026-06-22 | Marriner Kirsten | EVP - Chief Admin Officer | $2.5M | A — Grant or awardForm 4 footnoteF1 The Restricted Stock Units will vest in 3 equal installments - 1/3 on each of June 17, 2027, 2028 and 2029. | SEC |
| 2026-06-17 | 2026-06-22 | Hilt Angela C | EVP - Chief Legal Officer | $2.5M | A — Grant or awardForm 4 footnoteF1 The Restricted Stock Units will vest in full on the third anniversary of the grant date, June 17, 2029. | SEC |
| 2026-10-05 | 2026-10-07 | Rendle Linda J | Chief Executive Officer | $2.4M | A — Grant or awardForm 4 footnoteF1 Settlement of 2023 Performance Unit Grant that vested 10/5/26, which the reporting person has elected to defer pursuant to the 2005 Stock Incentive Plan. | SEC |
| 2025-10-03 | 2025-10-07 | Reynolds Eric H | EVP - Chief Operating Officer | $1.9M | A — Grant or awardForm 4 footnoteF1 Settlement of 2022 Performance Unit Grant, which vested 10/3/25. | SEC |
| 2025-09-04 | 2025-09-08 | Reynolds Eric H | EVP - Chief Operating Officer | $1.7M | M — Option exercise | SEC |
| 2025-10-03 | 2025-10-07 | Reynolds Eric H | EVP - Chief Operating Officer | $1.2M | F — Tax withholding (shares surrendered for taxes)3 Form 4 footnotesF2 Withholding of shares by the Company to satisfy tax obligations relating to vesting of restricted stock. F3 Withholding of shares by the Company to satisfy tax obligations relating to vesting of performance stock units. F4 Includes 739 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. | SEC |
| 2025-10-03 | 2025-10-07 | Grier Stacey | EVP - Executive Chief of Staff | $1.2M | A — Grant or awardForm 4 footnoteF1 Settlement of 2022 Performance Unit Grant that vested 10/3/25, which the reporting person has elected to defer pursuant to the 2005 Stock Incentive Plan. | SEC |
| 2025-09-16 | 2025-09-18 | Reynolds Eric H | EVP - Chief Operating Officer | $1.2M | A — Grant or awardForm 4 footnoteF1 The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2026, 2027, 2028, and 2029. | SEC |
| 2025-10-03 | 2025-10-07 | Rendle Linda J | Chief Executive Officer | $1.2M | F — Tax withholding (shares surrendered for taxes)3 Form 4 footnotesF2 Withholding of shares by the Company to satisfy tax obligations relating to vesting of performance stock units. F3 Withholding of shares by the Company to satisfy tax obligations relating to vesting of restricted stock. F4 Includes 4,274 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. | SEC |
| 2025-10-03 | 2025-10-07 | Marriner Kirsten | EVP - Chief Admin Officer | $1.1M | A — Grant or awardForm 4 footnoteF1 Settlement of 2022 Performance Unit Grant that vested 10/3/25. | SEC |
| 2026-09-23 | 2026-09-25 | Hyder Chris T | EVP-Chief Operating Officer | $1.1M | A — Grant or awardForm 4 footnoteF1 The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2027, 2028, 2029, and 2030. | SEC |
| 2025-10-03 | 2025-10-07 | Hilt Angela C | EVP - Chief Legal Officer | $1.1M | A — Grant or awardForm 4 footnoteF1 Settlement of 2022 Performance Unit Grant, which vested 10/3/25. | SEC |
The period balance: money in, money out
Across the Form 4 filings submitted between Sep 8, 2025 and Oct 7, 2026, The Clorox Company open-market activity adds up to 2 purchases worth $846k and 1 sale worth $1.9M. The net balance is $1.0M on the sell side.
Only codes P and S count, where an insider puts in or takes out their own money. A selling balance like The Clorox Company's is the norm in the S&P 500, where much of the pay comes as stock. It is not a recommendation to buy or sell: it is what was filed.
Every transaction, code by code
| Code | What it means | Trades | Reported amount |
|---|---|---|---|
| A | Grant or award | 34 | $49.0M |
| F | Tax withholding (shares surrendered for taxes) | 28 | $6.8M |
| P | Open-market purchase | 2 | $846k |
| M | Option exercise | 1 | $1.7M |
| S | Open-market sale | 1 | $1.9M |
| Total | Everything filed in the period | 66 | $60.2M |
All 66 rows carry an amount: the column adds up what was filed, no estimates. The code labels come from the SEC index.
Who has traded
Over the 15 months of history, 10 distinct people or entities have filed The Clorox Company transactions: 1 bought on the open market and 1 sold. Counted by CIK, the fixed number the SEC gives each filer, and not by name, which each filer types their own way.
| Filer | Role | Transactions | Bought (count) | Sold (count) | Last filed |
|---|---|---|---|---|---|
| Reynolds Eric H | EVP - Chief Operating Officer | 6 | — | $1.9M (1) | 2025-12-16 |
| Breber Pierre R | Director | 2 | $846k (2) | — | 2026-05-05 |
| Hyder Chris T | EVP-Chief Operating Officer | 10 | — | — | 2026-10-07 |
| Bellet Luc | EVP - Chief Financial Officer | 8 | — | — | 2026-10-07 |
| Hilt Angela C | EVP - Chief Legal Officer | 8 | — | — | 2026-10-07 |
| Marriner Kirsten | EVP - Chief Admin Officer | 8 | — | — | 2026-10-07 |
| Peck Laurene E | VP - CAO & Corp Controller | 7 | — | — | 2026-10-07 |
| Rendle Linda J | Chief Executive Officer | 7 | — | — | 2026-10-07 |
Shown here are the 8 who moved the most money, out of 10. The rest are in the full history, one link above. The name links to all their trades, in any company. "Transactions" counts any code; the money, open market only. Role: from their latest filing.
Month by month
By the month the trade was executed, not the month it was filed; months with no trades show zero. The busiest month was Sep 2025: 0 purchases and 1 sale, worth $1.9M. 12 of the 15 months have none.
| Month | Purchases | Amount | Sales | Amount |
|---|---|---|---|---|
| Aug 2025 | 0 | $0 | 0 | $0 |
| Sep 2025 | 0 | $0 | 1 | $1.9M |
| Oct 2025 | 0 | $0 | 0 | $0 |
| Nov 2025 | 1 | $417k | 0 | $0 |
| Dec 2025 | 0 | $0 | 0 | $0 |
| Jan 2026 | 0 | $0 | 0 | $0 |
| Feb 2026 | 0 | $0 | 0 | $0 |
| Mar 2026 | 0 | $0 | 0 | $0 |
| Apr 2026 | 0 | $0 | 0 | $0 |
| May 2026 | 1 | $429k | 0 | $0 |
| Jun 2026 | 0 | $0 | 0 | $0 |
| Jul 2026 | 0 | $0 | 0 | $0 |
| Aug 2026 | 0 | $0 | 0 | $0 |
| Sep 2026 | 0 | $0 | 0 | $0 |
| Oct 2026 | 0 | $0 | 0 | $0 |
The last month may be partial: a Form 4 is filed up to two business days later. The table does not say whether the pattern is good or bad; it says when it happened.
The Clorox Company (CLX) analysis page →
Other Consumer Defensive companies with insider trades
All 500 are listed in the section index →
Which insiders are buying their own company stock →
How to read this data
None of the 1 sale in the table is flagged as scheduled (10b5-1 plan), the kind signed months ahead and executed automatically. Clorox's 2 open-market purchases (code P) are the rare signal: insiders are already paid in stock, so buying more means putting in their own money. The latest filing is from Oct 7, 2026, and a Form 4 arrives up to two business days after the trade.
19 of the 20 rows in the table carry footnotes from the Form 4 itself, folded into the code column and copied verbatim; a row with no footnote means the filing has none.
Guide: Insider buying · all guides
What is behind these trades
The concepts on this page, explained from scratch in the Academy. Free, no account.
- What the efficiency hypothesis says and what it does NOT sayIf an insider's purchase is public and anyone can read it, is there any information left in it? That is the exact question that brings people here.
- Who really moves the market: the types of investorWho sits on the other side of each order, and where a company's own insiders fit among them.
- Supply, demand and price: why it rises and falls constantlyHow a piece of news ends up inside the price, and why the reaction to a filed sale is rarely the one you would expect.
Source: SEC EDGAR Form 4. This is a list of public facts, not financial advice or a recommendation to buy or sell.